Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
5',3'-nucleotidase, cytosolic pseudogene 1 (NT5CP1) is a human gene annotated as a pseudogene by HUGO Gene Nomenclature Committee and NCBI, meaning it resembles genes for nucleotidases but lacks coding capacity for a functional protein. It has no documented biological activity, no known disease association, and is not considered a drug target or biomarker. The gene is indexed under pseudogene locus type and is approved in nomenclature databases, but lacks experimental evidence for transcription or translation into a functional product
null
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 5',3'-nucleotidase, cytosolic pseudogene 1 (NT5CP1).